A recent trial showed its new 2-for-1 injection was more effective on both illnesses than existing individual shots.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The regulator sees some patents as ploys to keep companies from developing cheaper generic versions of 20 different brand-name drugs.
The asset manager announced annual revenues rose 14%, topping $20 billion for the first time, with record net inflows of $641 billion.
It’s basic Newtonian physics, as Boeing just learned: When the sky falls for a company, so, too, will the bottom line.
The company’s struggle gives us a glimpse into how the wider world of voice assistants is trying to keep up with the technology zeitgest.